European Neuropsychopharmacology
Volume 20, Issue 5 , Pages 327-335 , May 2010

No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment

  • Jens Drachmann Bukh

      Affiliations

    • Department of Psychiatry, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, University Hospital of Copenhagen, Rigshospitalet, Blegdamsvej 9, DK 2100 Copenhagen, Denmark. Tel.: +45 3545 6230; fax: +45 3545 6218.
    • ,
  • Camilla Bock

      Affiliations

    • Department of Psychiatry, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark
    • ,
  • Maj Vinberg

      Affiliations

    • Department of Psychiatry, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark
    • ,
  • Thomas Werge

      Affiliations

    • Research Institute of Biological Psychiatry, Mental Health Centre Sct. Hans, Copenhagen, Denmark
    • ,
  • Ulrik Gether

      Affiliations

    • Department of Neuroscience and Pharmacology, Faculty of Health Sciences, University of Copenhagen, Denmark
    • ,
  • Lars Vedel Kessing

      Affiliations

    • Department of Psychiatry, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark

Received 16 March 2009 ,Revised 3 September 2009 ,Accepted 12 November 2009.

References 

  1. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry. 1961;4:561–571
  2. Bondy B, Kuznik J, Baghai T, Schule C, Zwanzger P, Minov C, et al Lack of association of serotonin-2A receptor gene polymorphism (T102C) with suicidal ideation and suicide. Am. J. Med. Genet. 2000;96:831–835
  3. Brugha TS, Bebbington PE, Stretch DD, MacCarthy B, Wykes T. Predicting the short-term outcome of first episodes and recurrences of clinical depression: a prospective study of life events, difficulties, and social support networks. J. Clin. Psychiatry. 1997;58:298–306
  4. Bukh JD, Bock C, Vinberg M, Werge T, Gether U, Vedel KL. Interaction between genetic polymorphisms and stressful life events in first episode depression. J. Affect. Disord. 2009;119:107–115
  5. Chen C, Glatt SJ, Tsuang MT. The tryptophan hydroxylase gene influences risk for bipolar disorder but not major depressive disorder: results of meta-analyses. Bipolar. Disord. 2008;10:816–821
  6. Chen L, Lawlor DA, Lewis SJ, Yuan W, Abdollahi MR, Timpson NJ, et al. Genetic association study of BDNF in depression: finding from two cohort studies and a meta-analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008;147B:814–821
  7. Chorbov VM, Lobos EA, Todorov AA, Heath AC, Botteron KN, Todd RD. Relationship of 5-HTTLPR genotypes and depression risk in the presence of trauma in a female twin sample. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007;144:830–833
  8. Christiansen L, Tan Q, Iachina M, Bathum L, Kruse TA, McGue M, et al. Candidate gene polymorphisms in the serotonergic pathway: influence on depression symptomatology in an elderly population. Biol. Psychiatry. 2007;61:223–230
  9. Craddock N, Owen MJ, O'Donovan MC. The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons. Mol. Psychiatry. 2006;11:446–458
  10. Drago A, Serretti A. Focus on HTR2C: a possible suggestion for genetic studies of complex disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008;150:601–637
  11. First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS. The Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). Washington: American Psychiatric Press; 1997;
  12. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960;23:56–62
  13. Iwamoto K, Kato T. RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders. Neurosci. Lett. 2003;346:169–172
  14. Kato M, Serretti A. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol. Psychiatry. 2008;
  15. Kendler KS, Karkowski LM, Prescott CA. Stressful life events and major depression: risk period, long-term contextual threat, and diagnostic specificity. J. Nerv. Ment. Dis. 1998;186:661–669
  16. Kendler KS, Thornton LM, Gardner CO. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the “kindling” hypothesis. Am. J. Psychiatry. 2000;157:1243–1251
  17. Kilpatrick DG, Koenen KC, Ruggiero KJ, Acierno R, Galea S, Resnick HS, et al. The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults. Am. J. Psychiatry. 2007;164:1693–1699
  18. Mandelli L, Marino E, Pirovano A, Calati R, Zanardi R, Colombo C, et al. Interaction between SERTPR and stressful life events on response to antidepressant treatment. Eur. Neuropsychopharmacol. 2009;19:64–67
  19. Monroe SM, Thase ME, Hersen M, Himmelhoch JM, Bellack AS. Life events and the endogenous-nonendogenous distinction in the treatment and posttreatment course of depression. Compr. Psychiatry. 1985;26:175–186
  20. Munk-Jorgensen P, Mortensen PB. The Danish Psychiatric Central Register. Dan. Med. Bull. 1997;44:82–84
  21. Nakamura M, Ueno S, Sano A, Tanabe H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol. Psychiatry. 2000;5:32–38
  22. Paykel ES. The interview for recent life events. Psychol. Med. 1997;27:301–310
  23. Paykel ES. Basic concepts of depression. Dialogues. Clin. Neurosci. 2008;10:279–289
  24. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am. J. Psychiatry. 1992;149:999–1010
  25. Posternak MA, Zimmerman M. How accurate are patients in reporting their antidepressant treatment history?. J. Affect. Disord. 2003;75:115–124
  26. Posternak MA, Young D, Sheeran T, Chelminski I, Franklin CL, Zimmerman M. Assessing past treatment history: test–retest reliability of the Treatment Response to Antidepressant Questionnaire. J. Nerv. Ment. Dis. 2004;192:95–102
  27. Power T, Stewart R, Ancelin ML, Jaussent I, Malafosse A, Ritchie K. 5-HTTLPR genotype, stressful life events and late-life depression: no evidence of interaction in a French population. Neurobiol. Aging. 2008;Electronic publication ahead of print
  28. Praschak-Rieder N, Kennedy J, Wilson AA, Hussey D, Boovariwala A, Willeit M, et al Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study. Biol. Psychiatry. 2007;62:327–331
  29. Rasmussen HB, Werge TM. Novel procedure for genotyping of the human serotonin transporter gene-linked polymorphic region (5-HTTLPR)—a region with a high level of allele diversity. Psychiatr. Genet. 2007;17:287–291
  30. Sackeim HA. The definition and meaning of treatment-resistant depression. J. Clin. Psychiatry. 2001;62(Suppl 16):10–17
  31. Serretti A, Artioli P, Lorenzi C, Pirovano A, Tubazio V, Zanardi R. The C(−1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings. Int. J. Neuropsychopharmacol. 2004;7:453–460
  32. Serretti A, Artioli P, Quartesan R. Pharmacogenetics in the treatment of depression: pharmacodynamic studies. Pharmacogenet. Genomics. 2005;15:61–67
  33. Serretti A, Benedetti F, Zanardi R, Smeraldi E. The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2005;29:1074–1084
  34. Serretti A, Drago A, De RD. HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. Curr. Med. Chem. 2007;14:2053–2069
  35. Serretti A, Kato M, De RD, Kinoshita T. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol. Psychiatry. 2007;12:247–257
  36. Smeraldi E, Zanardi R, Benedetti F, Di BD, Perez J, Catalano M. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol. Psychiatry. 1998;3:508–511
  37. Strobel A, Gutknecht L, Rothe C, Reif A, Mossner R, Zeng Y, et al. Allelic variation in 5-HT1A receptor expression is associated with anxiety- and depression-related personality traits. J. Neural Transm. 2003;110:1445–1453
  38. Uher R, McGuffin P. The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis. Mol. Psychiatry. 2008;13:131–146
  39. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch. Gen. Psychiatry. 1990;47:589–593
  40. World Health Organisation. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organisation; 1992;
  41. Zalsman G, Huang YY, Oquendo MA, Burke AK, Hu XZ, Brent DA, et al. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am. J. Psychiatry. 2006;163:1588–1593

PII: S0924-977X(09)00255-7

doi: 10.1016/j.euroneuro.2009.11.004

European Neuropsychopharmacology
Volume 20, Issue 5 , Pages 327-335 , May 2010

Article Tools

* Image Usage & Resolution